Under construction – not a live service
Sign in
Not yet taking people in IsraelNo phase

Interactive virtual reality training for movement recovery after stroke or traumatic brain injury

Compares interactive and passive virtual reality in people rehabilitating after stroke or brain injury.

Plain-language title generated from the registry record
Registry title: Efficacy and Safety of 6Degrees MyMove Interactive Virtual Reality Compared to Passive Virtual Reality in Subacute Stroke and Traumatic Brain Injury Rehabilitation: A Randomized Controlled Trial

Key facts

Where
Tel Aviv, IsraelSee the site

Where in Israel

  • Reuth Rehabilitation Hospital - Tel AvivTel Aviv, IsraelNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Reuth Rehabilitation Hospital
Trial code
NCT07441798
Record updated
2 March 2026
Original description
Stroke and traumatic brain injury frequently result in persistent upper and lower limb motor impairment. While conventional rehabilitation improves outcomes, patient adherence and training intensity remain limiting factors. Immersive virtual reality (VR)-based therapy may enhance neuroplasticity by delivering high-intensity, task-oriented motor practice with enriched sensory feedback.Read full original descriptionShow less

Efficacy and Safety of 6Degrees MyMove Interactive Virtual Reality Compared to Passive Virtual Reality in Subacute Stroke and Traumatic Brain Injury Rehabilitation: A Randomized Controlled Trial

Stroke and traumatic brain injury frequently result in persistent upper and lower limb motor impairment. While conventional rehabilitation improves outcomes, patient adherence and training intensity remain limiting factors. Immersive virtual reality (VR)-based therapy may enhance neuroplasticity by delivering high-intensity, task-oriented motor practice with enriched sensory feedback.

This randomized controlled trial evaluates the efficacy and safety of the 6Degrees MyMove interactive VR system compared to passive VR exposure in individuals undergoing subacute inpatient rehabilitation after stroke or traumatic brain injury. Sixty participants will be randomized 1:1 to receive either interactive VR-based motor training or passive VR viewing, in addition to standard rehabilitation care, three times weekly for eight weeks.

The primary objective is to determine whether interactive VR leads to greater improvement in motor function compared to passive VR. Secondary outcomes include dexterity, gait speed, functional independence, psychological status, adherence, usability, and safety.

Inclusion: Time since neurological event: At least 2 weeks post-stroke or post-head injury; Motor impairment: Upper extremities: Presence of hemiparesis without complete paralysis. Participants receiving rehabilitation focused on functional transfer to the contralateral hand using compensatory or adaptive motor learning strategies will also be eligible. Lower extremities: Presence of partial voluntary movement sufficient to allow participation in rehabilitation training; Cognitive ability: Sufficient cognitive capacity to understand instructions and engage with VR-based training, as determined by the principal investigator and/or treating physician; Medical stability: Medically stable condition allowing participation in the training; Informed consent: Ability to provide written informed consent personally or via a legal guardian; Final eligibility will be determined by the principal investigator/ treating physician.

Exclusion: Severe cognitive or language impairment: Cognitive deficits or language comprehension impairments that prevent safe and meaningful participation; Medical contraindications:; Uncontrolled epilepsy; Severe vestibular or vertigo disorders; Neurological deficits interfering with VR: Severe hemispatial neglect or visual field deficits that interfere with VR use. Moderate neglect may be permitted at the investigator's discretion.

ClinicalTrials.gov NCT07441798